Lloyd Advisory Services LLC. Takes Position in McKesson Corporation $MCK

Lloyd Advisory Services LLC. acquired a new stake in McKesson Corporation (NYSE:MCK) in the 4th quarter, HoldingsChannel reports. The fund acquired 1,405 shares of the company’s stock, valued at approximately $1,152,000.

Several other large investors also recently made changes to their positions in the stock. Meiji Yasuda Asset Management Co Ltd. boosted its holdings in shares of McKesson by 0.5% in the 4th quarter. Meiji Yasuda Asset Management Co Ltd. now owns 2,262 shares of the company’s stock valued at $1,855,000 after buying an additional 11 shares during the last quarter. Obsidian Personal Planning Solutions LLC boosted its holdings in shares of McKesson by 2.9% in the 3rd quarter. Obsidian Personal Planning Solutions LLC now owns 426 shares of the company’s stock valued at $346,000 after buying an additional 12 shares during the last quarter. LRI Investments LLC boosted its holdings in shares of McKesson by 12.1% in the 4th quarter. LRI Investments LLC now owns 111 shares of the company’s stock valued at $91,000 after buying an additional 12 shares during the last quarter. Macroview Investment Management LLC boosted its holdings in shares of McKesson by 3.9% in the 4th quarter. Macroview Investment Management LLC now owns 322 shares of the company’s stock valued at $264,000 after buying an additional 12 shares during the last quarter. Finally, Berkshire Asset Management LLC PA boosted its holdings in shares of McKesson by 4.6% in the 3rd quarter. Berkshire Asset Management LLC PA now owns 294 shares of the company’s stock valued at $227,000 after buying an additional 13 shares during the last quarter. Institutional investors and hedge funds own 85.07% of the company’s stock.

McKesson Price Performance

Shares of McKesson stock opened at $765.30 on Friday. The business has a fifty day simple moving average of $838.23 and a two-hundred day simple moving average of $855.53. McKesson Corporation has a 1 year low of $637.00 and a 1 year high of $999.00. The company has a market capitalization of $91.99 billion, a price-to-earnings ratio of 19.89, a P/E/G ratio of 1.14 and a beta of 0.35.

McKesson (NYSE:MCK) last announced its quarterly earnings results on Thursday, May 7th. The company reported $11.69 earnings per share (EPS) for the quarter, beating the consensus estimate of $11.56 by $0.13. McKesson had a negative return on equity of 345.35% and a net margin of 1.18%.The business had revenue of $96.30 billion during the quarter, compared to the consensus estimate of $101.35 billion. During the same quarter last year, the firm posted $10.12 EPS. The company’s quarterly revenue was up 6.0% on a year-over-year basis. McKesson has set its FY 2027 guidance at 43.800-44.600 EPS. As a group, equities analysts anticipate that McKesson Corporation will post 44.29 earnings per share for the current fiscal year.

McKesson Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 1st. Shareholders of record on Monday, June 1st will be issued a dividend of $0.82 per share. The ex-dividend date of this dividend is Monday, June 1st. This represents a $3.28 annualized dividend and a yield of 0.4%. McKesson’s dividend payout ratio (DPR) is currently 8.53%.

Analysts Set New Price Targets

Several research firms have recently commented on MCK. Wall Street Zen raised McKesson from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd. Leerink Partners reissued an “outperform” rating and issued a $1,085.00 price objective on shares of McKesson in a report on Thursday, March 5th. TD Cowen increased their price objective on McKesson from $1,000.00 to $1,012.00 and gave the company a “buy” rating in a report on Thursday, February 5th. Morgan Stanley reissued an “overweight” rating and issued a $966.00 price objective on shares of McKesson in a report on Thursday, January 29th. Finally, JPMorgan Chase & Co. cut their price objective on McKesson from $1,107.00 to $1,015.00 and set an “overweight” rating for the company in a report on Friday, May 8th. Fourteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $968.87.

Insider Transactions at McKesson

In other McKesson news, EVP Michele Lau sold 2,725 shares of the firm’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $990.00, for a total transaction of $2,697,750.00. Following the completion of the sale, the executive vice president owned 3,247 shares of the company’s stock, valued at $3,214,530. This trade represents a 45.63% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.08% of the stock is owned by corporate insiders.

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.